The US Food and Drug Administration has issued 7 warning letters to companies illegally marketing products containing 7-hydroxymitragynine (7-OH), which is found in trace amounts in kratom.

“There are no FDA-approved drugs containing 7-OH, and it is illegal to market any drugs containing 7-OH,” the FDA said.

The U.S. Food and Drug Administration sent letters to seven companies that sell opioid alternative products containing ...

The FDA has issued warnings to seven companies for illegally marketing kratom-based products containing 7-OH, a compound not approved for food or supplements, citing safety concerns and unproven ...

The U.S. Food and Drug Administration has issued warning letters to 17 website operators for illegally selling unapproved and misbranded opioids online in violation of the Federal Food, Drug, and ...

The FDA recently announced that is has issued warning letters to 17 website operators for illegally selling opioids that are unapproved or misbranded, meaning they were sold without a prescription ...

Some medical researchers say 7-OH products made from kratom extracts could have the potential to create addiction problems, ...

The FDA sent a warning letter to EPH Technologies, accusing it of marketing and selling unapproved drugs. The products are sold under the names Detoxoplex, Sinoplex and Migrenza, and are marketed ...

FDA issues warning to AcelRx for making false and misleading claims about the risks and benefits of Dsuvia. [ press release ]. Silver Springs, MD: US Food and Drug Administration; February 16, 2021.

The U.S. Food and Drug Administration on Tuesday sent warning letters to nine online networks operating a total of 53 websites to stop illegally marketing unapproved versions of opioid medications.

A print advertisement of Alkermes Plc's addiction treatment, Vivitrol, is false or misleading as it omits important risk information associated with its use, the Food and Drug Administration said ...

The FDA sent a warning letter Tuesday to McKesson Corp. that said the company had failed to put adequate systems in place to properly flag illegitimate opioid medications and suspicious drug ...